{
  "paper": {
    "doi": null,
    "pmcid": "PMC_extracted",
    "title": "PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-\u03b2/Smad and PI3K/AKT/mTOR signaling",
    "authors": [
      "Not specified"
    ],
    "journal": "Not specified",
    "year": null,
    "study_type": "experimental",
    "eco_type": "in_vitro_in_vivo"
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "79b943b6f54c8c87c9947c3504758e5fe8d99315",
      "git_commit_short": "79b943b",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T22:26:09.539528Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 38.02
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "PSMD14",
      "class": "Gene",
      "name": "PSMD14",
      "synonyms": [
        "POH1",
        "RPN11",
        "Proteasome 26S Subunit, Non-ATPase 14"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9563",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "HMMR",
      "class": "Gene",
      "name": "HMMR",
      "synonyms": [
        "Hyaluronan-mediated motility receptor"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:5012",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "LUAD",
      "class": "Disease",
      "name": "Lung adenocarcinoma",
      "synonyms": [
        "LUAD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0152013",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "NSCLC",
      "class": "Disease",
      "name": "Non-small cell lung cancer",
      "synonyms": [
        "NSCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0007131",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "TGF-\u03b2",
      "class": "Gene",
      "name": "TGF-\u03b2",
      "synonyms": [
        "Transforming growth factor beta"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11766",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PI3K",
      "class": "Gene",
      "name": "PI3K",
      "synonyms": [
        "Phosphoinositide 3-kinase"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:8975",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "AKT",
      "class": "Gene",
      "name": "AKT",
      "synonyms": [
        "AKT serine/threonine kinase"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:391",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "mTOR",
      "class": "Gene",
      "name": "mTOR",
      "synonyms": [
        "mechanistic target of rapamycin"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:3942",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "Smad",
      "class": "Gene",
      "name": "Smad",
      "synonyms": [
        "SMAD family member"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:6768",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "Capzimin",
      "class": "Drug",
      "name": "Capzimin",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "Galunisertib",
      "class": "Drug",
      "name": "Galunisertib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1598392",
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "PMC_extracted:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_1",
      "text": "PSMD14 demonstrates elevated mRNA expression across multiple cancer types compared to normal tissues. In lung adenocarcinoma (LUAD), PSMD14 is upregulated not only at the transcriptional level but also at the protein level.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "expression_analysis",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_2",
      "text": "Kaplan\u2013Meier survival analysis demonstrated that patients with high PSMD14 expression had significantly worse overall survival (OS, p = 0.003), disease-specific survival (DSS, p = 0.001), progression-free interval (PFI, p < 0.001), and disease-free interval (DFI, p < 0.001) compared to those with low expression.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "survival_analysis",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_3",
      "text": "Using co-immunoprecipitation (Co-IP) assays, we confirmed a specific interaction between PSMD14 and HMMR. Subsequent knockdown and overexpression of PSMD14 in LUAD cell lines demonstrated that HMMR expression is positively regulated by PSMD14 at both the mRNA and protein levels.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "protein_interaction",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:4:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_4",
      "text": "PSMD14 knockdown markedly enhanced HMMR ubiquitination, whereas its overexpression reduced it. PSMD14 primarily cleaved K63-linked ubiquitin chains from HMMR.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "biochemical_assay",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:5:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_5",
      "text": "CCK-8 assays revealed that PSMD14 knockdown significantly suppressed proliferation in H1299 and PC9 cells, while its overexpression markedly enhanced proliferation in H1975 cells.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "cell_proliferation_assay",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:6:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_6",
      "text": "PSMD14 knockdown reduced TGF-\u03b2, p-Smad2/3 phosphorylation, and CD44 expression, whereas PSMD14 overexpression increased these markers. Similarly, PSMD14 knockdown decreased phosphorylation of mTOR, PI3K, and AKT, while its overexpression enhanced their activation.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "western_blot",
      "source": "extracted"
    },
    {
      "id": "PMC_extracted:results:7:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC_extracted",
      "text_span_id": "results_7",
      "text": "The PSMD14 inhibitor Capzimin exhibited potent anti-tumor effects in vitro and in vivo, and combination therapy with the TGF-\u03b2 inhibitor galunisertib demonstrated enhanced efficacy.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "drug_treatment",
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "PSMD14",
      "predicate": "INCREASES_RISK",
      "object": "LUAD",
      "evidence_ids": [
        "PMC_extracted:results:1:llm",
        "PMC_extracted:results:2:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PSMD14",
      "predicate": "ASSOCIATED_WITH",
      "object": "HMMR",
      "evidence_ids": [
        "PMC_extracted:results:3:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.95,
      "properties": {
        "interaction_type": "protein-protein"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PSMD14",
      "predicate": "REGULATES",
      "object": "HMMR",
      "evidence_ids": [
        "PMC_extracted:results:3:llm",
        "PMC_extracted:results:4:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.95,
      "properties": {
        "mechanism": "K63-linked deubiquitination"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PSMD14",
      "predicate": "ACTIVATES",
      "object": "TGF-\u03b2",
      "evidence_ids": [
        "PMC_extracted:results:6:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.95,
      "properties": {
        "pathway": "TGF-\u03b2/Smad"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PSMD14",
      "predicate": "ACTIVATES",
      "object": "PI3K",
      "evidence_ids": [
        "PMC_extracted:results:6:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.95,
      "properties": {
        "pathway": "PI3K/AKT/mTOR"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "Capzimin",
      "predicate": "TREATS",
      "object": "LUAD",
      "evidence_ids": [
        "PMC_extracted:results:7:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "PSMD14 inhibition"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "Galunisertib",
      "predicate": "TREATS",
      "object": "LUAD",
      "evidence_ids": [
        "PMC_extracted:results:7:llm"
      ],
      "source_papers": [
        "PMC_extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "TGF-\u03b2 inhibition",
        "combination_therapy": true
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "This study demonstrates that PSMD14 acts as a key driver of LUAD progression through stabilization of HMMR via K63-linked deubiquitination",
    "The PSMD14-HMMR axis coordinately activates both TGF-\u03b2/Smad and PI3K/AKT/mTOR signaling pathways",
    "Combination therapy with PSMD14 and TGF-\u03b2 inhibitors shows enhanced therapeutic efficacy"
  ]
}